Top 50 Medical Startup Investors in Oceania in May 2026

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Pre-Seed, Series A
Australia, United States, Hong Kong

Portfolio highlights

CUZIN — Providing a surprisingly human shopping experience. Trusted and secure. Millions of domains to choose from.
CLIQ — We understand firsthand the impact of social isolation and the longing for genuine human connection. CLIQ was born from a vision to address this issue and to fundamentally transform the way that we meet new people and form connections.
Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.

Show all investments...

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

Investment focus

Biotechnology, Health Care, Medical
Series A, Seed, Series B
Australia, United States, United Kingdom

Portfolio highlights

Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.

Show all investments...

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Seed, Series B
Australia, United States, United Kingdom

Portfolio highlights

Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
VeriQuantix — VeriQuantix was spun out of the University of Queensland. VeriQuantix is an Australian startup specializing in cybersecurity, focusing on quantum technology to enhance the security of optical fiber communication networks. Their core innovation, Quantum Link Verification (QLV), is designed to detect and alert network operators to physical tappingattempts and intercept cyber attacks on fiber optic networks. This technology leverages quantum principles, specifically entangled photons, to verify the trustworthiness of network links by ensuring that any unauthorized access disrupts photon entanglement and triggers immediate alerts.
Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.

Show all investments...

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Investment focus

Biotechnology, Health Care, Manufacturing
Series A, Seed, Funding Round
Australia, United States, United Kingdom

Portfolio highlights

BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com

Show all investments...

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

Investment focus

Health Care, Software, Information Technology
Seed, Series A, Funding Round
Australia, United States, United Kingdom

Portfolio highlights

Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
Great Wrap — The only Australian made and owned compostable cling wrap
Conserving Beauty — Acne Care Reimagined. Skincare formulated for for acne-prone and sensitive skin. Clinically tested and shown to cause no dermal irritation or sensitization. Australian and STEM Female Founded.

Show all investments...

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

Investment focus

Biotechnology, Medical, Health Care
Seed, Funding Round, Series A
Australia, United States, United Kingdom

Portfolio highlights

BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
Lenexa Medical — Lenexa Medical is an Australian based MedTech company.
Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.

Show all investments...

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Investment focus

Software, Artificial Intelligence, Manufacturing
Seed, Series A, Series B
Australia, United States, Philippines

Portfolio highlights

Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Prospection — Helping pharmaceutical brand teams unlock patient-centric intelligence to drive better patient care outcomes and capture market share opportunities.
QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.

Show all investments...

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Investment focus

Software, Artificial Intelligence, Information Technology
Pre-Seed, Seed, Series A
Singapore, Australia, United Kingdom

Portfolio highlights

Synthium — Synthium offers Cognition-as-a-Service (CaaS) for consumer robotics, using gamified web-based simulations to crowdsource human cognitive data for training robot AI models. Users engage in robotics tasks like spatial navigation via webcam and microphone inputs, generating diverse datasets for model training across robot types such as humanoids anddrones. Data captures human intuition in dynamic environments, enabling scalable AI development without physical robots.
Alchemyst AI — Alchemyst AI is an innovative generative AI software-as-a-service (SaaS) startup that leverages cutting-edge artificial intelligence technology to deliver unique solutions tailored to various industries. Alchemyst aims to empower businesses to harness the potential of generative AI for enhanced creativity, efficiency, and decision-making.We arebuilding force multipliers within teams across various verticals - starting with Maya, our first Alchemyst for Sales Development. We would soon be horizontally scaling to other roles as well, integrating into wherever you work.Since inception, we have taken a bottom-up approach to building our platform as opposed to a top-down approach usually seen in SaaS products - keeping the client experience first.
Cooper Pet Care — Just Russel honden- en kattenvoeding op maat. Op basis van ras, leeftijd, gezondheid en gewicht. Makkelijker voor jou, beter voor je huisdier!

Show all investments...

EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.

Investment focus

Software, SaaS, Information Technology
Series A, Seed, Funding Round
Australia, New Zealand, United States

Portfolio highlights

Blend AI — Making online advertising easy for everyone. Blend connects to your store helping you measure the impact your ads are having on revenue.
Mutiny — Mutiny is an analytics platform for marketing investments with a sizable customer base.
Fergus — Fergus is a smart field service management software for service businesses. Make job management easy and carry out work better with our all-in-one solution.

Show all investments...

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
New Zealand, United States, United Kingdom

Portfolio highlights

Foxglove — Foxglove is visualization and management for temporal and multimodal data. It's used by robotics companies to scale and accelerate development.
Antioch — Antioch is the development and simulation platform for autonomy teams to accelerate timelines, rigorously evaluate autonomous systems, and deploy with confidence.
HealthNow — HealthNow provides accessible healthcare services that give you control of your health. Manage how you access care, when you need it.

Show all investments...

Right Click Capital - Australian Venture Capital Firm

Investment focus

Software, SaaS, Information Technology
Seed, Series A, Funding Round
Australia, Singapore, United States

Portfolio highlights

black.ai — Build smarter spaces with Black.ai
Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation

Show all investments...

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Investment focus

Health Care, Biotechnology, Therapeutics
Seed, Series A, Funding Round
United Kingdom, United States, Australia

Portfolio highlights

Lumai — Lumai delivers optical compute for the inference era, enabling up to 50x AI performance and 90% less power. Supports billion-parameter LLMs today.
Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
Diffblue — Diffblue Testing Agent generates, verifies, and fixes unit tests autonomously across enterprise codebases.

Show all investments...

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

Investment focus

SaaS, Software, Health Care
Seed, Pre-Seed, Series A
Australia, United States

Portfolio highlights

Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
Kapiche — Customer intelligence for CX, support and product teams who need to understand their customers accross more than just surveys. Analyze 100% of customer conversations to prevent churn and accelerate growth.
Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.

Show all investments...

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
Australia, United States, United Kingdom

Portfolio highlights

Qlarifi — Consumer lending decisions transformed with real time, comprehensive data.
Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.

Show all investments...

Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.

Investment focus

EdTech, Medical, Education
Seed
Australia

Portfolio highlights

PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.

Show all investments...

Larsen Ventures is a lean, driven and strategic venture investment firmWe believe in alignment, long-term thinking & investor due diligence  We like metrics, traction & perseverance  We invest in people 1/3 of our focus is on Health and Education;  We like the thematic & overall gains for society2/3 of our time is spentlearning from peers, digging into research,  chasing leads & hanging out on caffeinated zooms in the endless search for;Founders with Traction  Founders with Insight  Founders with Perseverance and Courage  Founders with an innate ability to question EverythingWe have patient capital that engages & contributes to your Journey  Accelerate your business with our portfolios' intellectual capital

Investment focus

Software, Education, SaaS
Seed, Series A, Series B
Australia, United States, United Kingdom

Portfolio highlights

Go1 — Simplify employee training with one subscription that delivers essential learning from 250+ providers, integrated seamlessly into your HR tech stack.
OneMRI — A comprehensive whole-body MRI. Radiation-free, clinically reviewed, and explained by doctors.
Vitruvian Form — Vitruvian manufactures a connected fitness hardware, develops software and fitness class content.

Show all investments...

Investing in the deep science and technology that can propel humanity towards a radically better future.

Investment focus

Biotechnology, Artificial Intelligence, Software
Series A, Series B, Seed
United States, United Kingdom, Canada

Portfolio highlights

Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
Fano Labs — We are one of the leading AI companies specialising on Language AI technologies for enterprises in customer services, compliance and other lines of businesses.
Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.

Show all investments...

Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!

Investment focus

Software, Biotechnology, Renewable Energy
Series A, Series B, Series C
Australia, United Kingdom, United States

Portfolio highlights

Airwallex — Established in Melbourne in 2015, Airwallex is a global payments fintech that enables businesses to operate anywhere, anytime.In today’s fast-changing digital era, Airwallex's purpose is to empower businesses of all sizes to grow without borders, and by doing so, contribute to the global economy. With technology at its core, Airwallex builta proprietary global financial infrastructure platform to help businesses transact, collect and pay in any foreign currency across 130+ countries and 50+ currencies, without the constraints of the traditional global financial system.
Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.

Show all investments...

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

Investment focus

Software, Apps, EdTech
Seed, Series A, Funding Round
Australia, United States, New Zealand

Portfolio highlights

Sphere — Live courses led by vetted experts for professionals who want to advance their careers
Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
Visionary Machines — Superior perception for next-generation autonomy

Show all investments...

Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.

Investment focus

Events, Sports, Cycling
Pre-Seed
Hong Kong

Portfolio highlights

GXE — At GXE, our mission is to build the all-in-one platform for unlisted assets and funds management. We provide investors, fund managers, and family offices with the tools they need to succeed and enable them to focus on their portfolios and investors whilst GXE takes care of everything else. A licensed financial services company, GXE holdsAustralian Financial Services Licence 460870 issued by the Australian Securities and Investments Commission. GXE welcomes clients across sectors including corporate, family offices, pension and superannuation fund managers, private equity, property, and venture capital.
VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI

Show all investments...

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

Investment focus

Software, Financial Services, FinTech
Funding Round, Series B, Convertible Note
Australia, United States, United Kingdom

Portfolio highlights

Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.

Show all investments...

Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.

Investment focus

Medical, Facial Recognition, Artificial Intelligence
Seed, Funding Round
Australia

Portfolio highlights

Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.

Show all investments...

Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.

Investment focus

Software, SaaS, Health Care
Seed, Angel, Series A
Australia, United States

Portfolio highlights

Okkular — Okkular is an AI based fashion tech startup.
iiShield — iiShield aims to improve patient outcomes and surgeon training in transplant surgery by providing effective organ heat protection.
Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.

Show all investments...

Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.

Investment focus

Software, E-Commerce, Health Care
Seed, Series A, Funding Round
Australia, United States

Portfolio highlights

OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!

Show all investments...

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

Investment focus

Software, Information Technology, Health Care
Funding Round, Seed, Angel
New Zealand, United States, United Kingdom

Portfolio highlights

Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
HealthNow — HealthNow provides accessible healthcare services that give you control of your health. Manage how you access care, when you need it.

Show all investments...

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

Investment focus

Software, Artificial Intelligence, SaaS
Seed, Series A, Pre-Seed
Australia, United States, New Zealand

Portfolio highlights

Syenta — Syenta is transforming the electronics manufacturing sector. Our patented fabrication method enables the 3D printing of multi-material electronics with fewer steps and less waste.
Blinq — Blinq makes it easy to share your contact details via QR code scanning on the mobile app.
Gilmour Space Technologies — Gilmour Space is a rocket company in Australia that is developing and launching low-cost small satellite launch vehicles. All orbits, all planets: https://www.gspacetech.com

Show all investments...

Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.

Investment focus

Software, Construction, SaaS
Funding Round, Seed, Convertible Note
Australia, United States

Portfolio highlights

SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.

Show all investments...

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

Investment focus

Software, Enterprise Software, Internet
Series A, Series B, Funding Round
United States, Australia, Philippines

Portfolio highlights

Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,328,201 freelance designers compete to create amazing designs for your business. Start Today!
Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.

Show all investments...

FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.

Investment focus

Medical, Health Care, Medical Device
Seed, Series A
Australia

Portfolio highlights

personr — Single source of truth for AML compliance
Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
VitalTrace — VitalTrace develops advanced biosensor technology to support safer childbirth. Our real-time fetal monitoring system helps detect distress during labour, empowering clinicians with data-driven decisions for better outcomes.

Show all investments...

Privately Held Companies

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Series C
United States, Canada, Australia

Portfolio highlights

OutcomesAI — OutcomesAI operates as a healthcare company, that combines AI Voice Agents with licensed nurses to deliver safe, scalable care across health systems.
ABK Biomedical — At ABK biomedical, we are focused on developing novel Y90 radioembolization treatment options for patients with hypervascular liver tumors
Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.

Show all investments...

The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.

Investment focus

Health Care, Manufacturing, Software
Funding Round, Series A, Seed
Australia, United States, Philippines

Portfolio highlights

EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
Fyton Bio — FytonBio is a privately held, preclinical-stage biopharmaceutical company specializing in biotechnology research. Their core mission is to achieve functional cures for autoimmune and inflammatory diseases by deleting pathogenic immune cells. The company focuses on developing monoclonal antibodies capable of highly specific depletion of such cellsto durably alter disease progression.
Myostellar — Myostellar is creating a first-in-class, highly differentiated biologic therapy that stimulates muscle stem cells to promote muscle regeneration with no fibrosis.

Show all investments...

Kurt Alexander

Investment focus

Mining, Retail, Medical
Seed, Funding Round
Australia

Portfolio highlights

QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.

Show all investments...

Investing in great people solving hard problems to create a better future.

Investment focus

Medical Device, Medical, Health Care
Seed, Series A
New Zealand, Australia

Portfolio highlights

PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.

Show all investments...

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

Investment focus

Biotechnology, Robotics, Nanotechnology
Seed
New Zealand, United States

Portfolio highlights

Ligar — Revolutionising molecular extraction through nanotechnology (molecularly imprinted polymers)
Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
PowerON — Dielectric Elastomers for Soft Robotics

Show all investments...

Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.

Investment focus

Medical, Health Care, Therapeutics
Pre-Seed
Australia

Portfolio highlights

Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.
Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
Psychae Therapeutics — Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses

Show all investments...

Jelix is an early-stage venture capital firm backing daring founders in Australia and New Zealand.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Funding Round
Australia, New Zealand, United States

Portfolio highlights

PropHero — Invest wisely in real estate There is an easier way to invest in real estate. Whether you are just getting started or already on your investment journey, at Pro
Fugu — Cheap green carbon at scale for the dawn of the e-fuel age
Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.

Show all investments...

BetterLabs is an early-stage venture capital fund and venture studio based in Perth, Australia. Backed by RAC the fund invests in technology and opportunities that impact next-generation insurance, clean technology, mobility, work and money. The studio creates ventures to solve challenges in these domains and we also invest in them.

Investment focus

Education, E-Commerce, Artificial Intelligence
Seed, Grant, Pre-Seed
Australia, United States

Portfolio highlights

upcover — upcover is Australia's award winning Online business insurance provider for All type of business owners, startups, consultants, freelancers and gig economy workers in Australia. Get a quote online today.
WeMoney — WeMoney is focused on obtaining an Open Banking license so that the Fintech firm can gain access to customer banking data, which may be used to improve the quality of services offered to them.WeMoney’s platform lets users keep track of their pending utility bills and other recurring payments. The platform also aims to help customers with managingtheir savings and monitoring their monthly income. Joveski revealed that his company is also developing features that will use behavioral science and AI to help users make better or more informed financial decisions.
Loopit — Loopit is the complete end-to-end software & professional services platform solution for car subscription to boost dealership & profitability.

Show all investments...

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Investment focus

Software, Information Technology, SaaS
Seed, Series A, Pre-Seed
New Zealand, United States, China

Portfolio highlights

EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
Ivo — Ivo reduces the time, effort, and cost of negotiating agreements.

Show all investments...

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

Investment focus

Medical, Health Care, Biotechnology
Series A
Australia

Portfolio highlights

Verva Pharmaceuticals — Verva Pharmaceuticals Ltd. (“Verva”) was formed in December, 2007 by consolidation of key diabetes assets, discovery technologies and targets resident in Autogen Research Ltd. (formerly the diabetes-focused subsidiary of ChemGenex Pharmaceuticals) with those of obesity drug development company Adipogen Pharmaceuticals Pty Ltd. The combined productportfolio, technologies and expertise provide a substantial opportunity for rapid clinical progress and growth in high-value markets with a significant unmet medical need.Verva operates in a completely virtual mode, managed by a CEO and Directors with extensive international product development and partnering experience. Verva’s founding research was undertaken at the Metabolic Research Unit of Deakin University in Geelong, Australia; a state-of-the-art facility providing access to key in vitro and in vivo models and capabilities. Verva has subsequently engaged expert scientists, clinicians, technical advisers and contract research organisations worldwide to implement the Company’s research and development strategy.
Protagonist Therapeutics — Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.

Show all investments...

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

Investment focus

Biotechnology, Health Care, Therapeutics
Series C, Series B, Series A
United States, Israel, Australia

Portfolio highlights

IpiNovyx Bio — Orange Grove Bio partners with leading research universities to advance preclinical biotech programs in the oncology space. The company leverages its venture capital and drug development expertise to help patients and build biotech ecosystems.
Evox Therapeutics — Evox Therapeutics is a privately held, Oxford-based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. Backed by leading Life Sciences Venture Capital groups and supported by a comprehensive intellectualproperty portfolio, Evox’s mission is to positively impact human health by creating novel exosome-based therapeutics for the treatment of various severe diseases with limited options for patients and their families.Evox has created substantial proprietary technology to modify exosomes using various molecular engineering, drug loading, and targeting strategies to facilitate targeted drug delivery to organs of interest, including the brain and the central nervous system. Exosome-based drugs have the potential to address some of the limitations of protein, antibody and nucleic acid-based therapies by enabling delivery to cells and tissues that are currently out of reach using other drug delivery technologies. Evox is leading the development within this emerging therapeutic space.
Kymera Therapeutics — Advancing targeted protein degradation to deliver next-generation medicines

Show all investments...

Catherine Lacavera is the Chief Legal Officer of ShipBob. She previously worked at Color Health as a Chief Legal Officer. Catherine Lacavera attended the University of Toronto.

Investment focus

Medical, Health Care, Biotechnology
Seed, Pre-Seed
Canada, Australia

Portfolio highlights

Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.

Show all investments...

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

Investment focus

Software, SaaS, Video
Seed, Series A, Funding Round
New Zealand, United States, China

Portfolio highlights

eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.

Show all investments...

At Olympus, we put a lot of good back into the world, and what we do, really matters.

Investment focus

Medical, Biotechnology, Health Care
Grant, Series A, Series C
United States, New Zealand

Portfolio highlights

Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
Swan EndoSurgical — Swan EndoSurgical provides endoluminal surgical robotic systems that will enhance patient care everywhere.
On Target Laboratories — ON TARGET LABORATORIES discovers and develops fluorescent markers to target and illuminate cancer during surgery so it can be removed more completely.

Show all investments...

Luke & Janelle Roberts

Investment focus

Mining, Retail, Medical
Seed
Australia

Portfolio highlights

QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.

Show all investments...

Jutech Pty Ltd

Investment focus

Mining, Retail, Medical
Seed
Australia

Portfolio highlights

QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.

Show all investments...

Flying Kiwi Angels ? Helping Kiwi Startups

Investment focus

Software, Information Technology, Apps
Seed, Angel, Pre-Seed
New Zealand

Portfolio highlights

FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.

Show all investments...

Andrew R Banks

Investment focus

Grocery, Medical, Health Care
Seed
Australia

Portfolio highlights

Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.

Show all investments...

HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.

Investment focus

Virtual Reality, Software, Augmented Reality
Series A, Seed, Funding Round
United States, Taiwan, China

Portfolio highlights

Bitmark — An archive of digital property rights infrastructure.
Hexa — Elevate your eCommerce experience with a 3D tech-stack that lets you create, manage, analyze, and distribute your 3D commerce assets.
Camsense — Camsense focuses on R&D and manufacturing of vision space positioning technology. It provides customers with highly precise sensors with its self-developed core algorithm and chips. Its products can be applied in consumer robots, industrial test, and surgeries.

Show all investments...